Patients with XIAP deficiency are at high risk for hemophagocytic lymphohistiocytosis [149] and usually present with inflammatory manifestations, including Crohn’s-like bowel disease [150]. The gene discussed is XIAP; the disease is hyperinsulinemic hypoglycemia, familial, 4.